ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "B cells"

  • 2022 American Transplant Congress

    Faster B Cell Rebound is Observed Following Xenotransplantation Compared to Allotransplantation in a Highly Sensitized Nonhuman Primate Kidney Transplantation Model

    I. DeLaura, M. Manook, D. Olaso, J. Yoon, R. Baldi, S. Knechtle, J. Kwun

    Surgery, Duke Transplant Center, Durham, NC

    *Purpose: Xenotransplantation outcomes have been greatly improved due to the advent of genetically engineered pigs and agents targeting the CD40-CD40L signaling pathway. However, studies have…
  • 2022 American Transplant Congress

    Marginal Zone B Cells Support T Cell Reconstitution Following ATG Lymphoablation in Heart Allograft Recipients.

    Y. Yamamoto, R. Fan, M. Nicosia, V. Gorbacheva, R. Fairchild, A. Valujskikh

    Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH

    *Purpose: Lymphoablation with anti-thymocyte globulin (ATG) is a common therapy in solid organ transplantation. However homeostatic proliferation of pre-existing memory T cells undermines the graft-prolonging…
  • 2022 American Transplant Congress

    TNFRSF13B Genotype Determines the Properties of Donor-Specific B Cells

    M. Cascalho1, M. Garcia de Mattos Barbosa1, T. Pasieka1, E. Farkash2, R. Sung3, M. Doshi4, J. Platt4

    1Surgery, University of Michigan, Ann Arbor, MI, 2Pathology, University of Michigan, Ann Arbor, MI, 3University of Michigan Health System, Ann Arbor, MI, 4University of Michigan, Ann Arbor, MI

    *Purpose: The TNFRSF13B gene is among the 5% most polymorphic genes in humans. The phenotypes of the most frequent TNFRSF13B variants in humans and mice…
  • 2022 American Transplant Congress

    How Does Anti-CD38 Antibody Treatment (Daratumumab) Impact Immunological Assessment in Solid Organ Transplantation?

    S. Ho1, K. Putnam2, C. Peiter2, W. Herczyk2, J. Gerlach3, E. Campagnaro4, Y. Lu4, K. Woodside4, M. Cusick4

    1Gift of Hope Organ & Tissue Donor Network, Itasca, IL, 2Gift of Life Michigan, Ann Arbor, MI, 3Michigan State University, East Lansing, MI, 4University of Michigan Medicine, Ann Arbor, MI

    *Purpose: We report the first case of Dara interference of routine pre-transplant (Tx) crossmatch (XM) repeatedly causing aberrant false positives which inadvertently delayed Tx for…
  • 2022 American Transplant Congress

    Complement 5 Regulation Ameliorates Antibody-Mediated Rejection After Liver Transplantation in Rats

    T. Tajima1, K. Hata1, J. Kusakabe1, H. Miyauchi1, X. Zhao1, S. Kageyama1, T. Okamoto1, Y. Wang2, E. Hatano1

    1Dept. of HBP Surgery & Transplantation, Kyoto University, Kyoto, Japan, 2Alexion Pharmaceuticals Inc., New Haven, CT

    *Purpose: Antibody-mediated rejection (AMR) is a refractory rejection after donor-specific antibody (DSA)-positive or blood-type incompatible organ transplantation. Since AMR significantly deteriorates transplant outcomes, there is…
  • 2022 American Transplant Congress

    Influence of Regulatory B Cells on B Cells

    Q. Fu1, K. M. Lee2, K. Deng2, D. Agarwal1, R. Matheson3, T. Press1, J. Lei4, H. Yang5, C. LeGuern2, S. Deng5, J. F. Markmann2

    1Center for Transplant Science, MGH, Boston, MA, 2Massachusetts General Hospital, Boston, MA, 3Transplantation Surgery Research, Massachusetts General Hospital, Boston, MA, 4Surgery, Mass General, Boston, MA, 5Sichuan Provincial People's Hospital, University of Electronic Sciences and Technology of China, Chengdu, China

    *Purpose: Our previous study showed that Bregs-TLR, one type of previously studied Breg expanded in vitro, are capable of suppressing naïve B cell proliferation in…
  • 2022 American Transplant Congress

    Peripheral Blood Immune Cell Profiles of Corneal Transplant with and without Acute Rejection

    J. Hjortdal1, M. Griffin2, C. C. Murphy3, S. Brouard4, N. Degauque4

    1Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark, 2National University of Ireland, Galway, Galway, Ireland, 3Royal Victoria Eye and Ear Hospital, Dublin, Ireland, 4Université de Nantes, CHU Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, ITUN, Nantes, France

    *Purpose: Acute rejection (AR) of allogeneic corneal transplantation (CT) has a profound effect on subsequent graft survival, indicating that immunological damage is often not fully…
  • 2022 American Transplant Congress

    Dynamic Changes in Titer and Specificity Autoantibodies in Chronic Bm12 to B/6 Kidney Rejection

    I. Sayin1, D. Yin1, D. Ghosh2, M. Clark2, A. Chong1

    1Department of Surgery, University of Chicago, Chicago, IL, 2Department of Medicine, University of Chicago, Chicago, IL

    *Purpose: Loss of autoreactive B cell tolerance and production of non-HLA autoantibodies have been observed in patients undergoing chronic rejection, however, how autoreactive B cells…
  • 2022 American Transplant Congress

    Characterization of GZMB+ Bregs Transcriptome and Their Impact on Target Cells in Single-Cell RNA-seq

    N. Sailliet, H. Le Mai, A. Dupuy, F. Cynthia, M. Chesneau, J. Poschmann, R. Danger, S. Brouard

    CRTI- INSERM UMR 1064, Nantes, France

    *Purpose: During the inflammatory process, the immune system capacity to regulate itself is mandatory to balance effector positive feedback, avoid allergies and autoimmunity. Different subsets…
  • 2022 American Transplant Congress

    Long-Term Kidney Allotransplant Acceptance is Defined by a Shift from a T Cell to a B Cell Rich Immune Microenvironment Within the Graft

    E. S. Szuter1, T. Yokose1, M. T. Guinn1, J. Ge2, I. Rosales3, B. Kwon4, P. S. Russell1, A. Cuenca2, D. Kreisel5, P. Sage6, J. C. Madsen1, R. B. Colvin3, A. Alessandrini1

    1Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, 2Department of Surgery, Boston Children's Hospital, Boston, MA, 3Department of Pathology, Massachusetts General Hospital, Boston, MA, 4Harvard College, Cambridge, MA, 5Department of Surgery, Washington University, St. Louis, MO, 6Transplantation Research Center, Renal Division, Brigham and Women’s Hospital, Boston, MA

    *Purpose: Mouse kidney allografts are spontaneously accepted in select, fully-mismatched donor-recipient strain combinations, such as DBA/2J to C57BL/6 (B6). Tolerant renal grafts develop aggregates of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 35
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences